The global market for Pemetrexed Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pemetrexed Injection players cover Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma and Seacross Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pemetrexed Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pemetrexed Injection market, with both quantitative and qualitative data, to help readers understand how the Pemetrexed Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Pemetrexed Injection market and forecasts the market size by Type (0.5g Bottle and 0.2g Bottle,), by Application (Non Squamous Non-Small Cell Lung Cancer and Squamous Cell Non-Small Cell Lung Cancer.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
0.5g Bottle
0.2g Bottle
Segmentation by application
Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company?????
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Pemetrexed Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Pemetrexed Injection market size (sales and revenue) and CAGR, Pemetrexed Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pemetrexed Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pemetrexed Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pemetrexed Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma, Seacross Pharmaceuticals, Simcere Pharmaceutical Group, Qilu Pharmaceutical, Pfizer and Jiangsu Anda Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pemetrexed Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pemetrexed Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pemetrexed Injection by Country/Region, 2017, 2022 & 2028
2.2 Pemetrexed Injection Segment by Type
2.2.1 0.5g Bottle
2.2.2 0.2g Bottle
2.3 Pemetrexed Injection Sales by Type
2.3.1 Global Pemetrexed Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Pemetrexed Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pemetrexed Injection Sale Price by Type (2017-2022)
2.4 Pemetrexed Injection Segment by Application
2.4.1 Non Squamous Non-Small Cell Lung Cancer
2.4.2 Squamous Cell Non-Small Cell Lung Cancer
2.5 Pemetrexed Injection Sales by Application
2.5.1 Global Pemetrexed Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Pemetrexed Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pemetrexed Injection Sale Price by Application (2017-2022)
3 Global Pemetrexed Injection by Company
3.1 Global Pemetrexed Injection Breakdown Data by Company
3.1.1 Global Pemetrexed Injection Annual Sales by Company (2020-2022)
3.1.2 Global Pemetrexed Injection Sales Market Share by Company (2020-2022)
3.2 Global Pemetrexed Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Pemetrexed Injection Revenue by Company (2020-2022)
3.2.2 Global Pemetrexed Injection Revenue Market Share by Company (2020-2022)
3.3 Global Pemetrexed Injection Sale Price by Company
3.4 Key Manufacturers Pemetrexed Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Injection Product Location Distribution
3.4.2 Players Pemetrexed Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pemetrexed Injection by Geographic Region
4.1 World Historic Pemetrexed Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Pemetrexed Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pemetrexed Injection Annual Revenue by Geographic Region
4.2 World Historic Pemetrexed Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Pemetrexed Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pemetrexed Injection Annual Revenue by Country/Region
4.3 Americas Pemetrexed Injection Sales Growth
4.4 APAC Pemetrexed Injection Sales Growth
4.5 Europe Pemetrexed Injection Sales Growth
4.6 Middle East & Africa Pemetrexed Injection Sales Growth
5 Americas
5.1 Americas Pemetrexed Injection Sales by Country
5.1.1 Americas Pemetrexed Injection Sales by Country (2017-2022)
5.1.2 Americas Pemetrexed Injection Revenue by Country (2017-2022)
5.2 Americas Pemetrexed Injection Sales by Type
5.3 Americas Pemetrexed Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Injection Sales by Region
6.1.1 APAC Pemetrexed Injection Sales by Region (2017-2022)
6.1.2 APAC Pemetrexed Injection Revenue by Region (2017-2022)
6.2 APAC Pemetrexed Injection Sales by Type
6.3 APAC Pemetrexed Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pemetrexed Injection by Country
7.1.1 Europe Pemetrexed Injection Sales by Country (2017-2022)
7.1.2 Europe Pemetrexed Injection Revenue by Country (2017-2022)
7.2 Europe Pemetrexed Injection Sales by Type
7.3 Europe Pemetrexed Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pemetrexed Injection by Country
8.1.1 Middle East & Africa Pemetrexed Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pemetrexed Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Pemetrexed Injection Sales by Type
8.3 Middle East & Africa Pemetrexed Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed Injection
10.3 Manufacturing Process Analysis of Pemetrexed Injection
10.4 Industry Chain Structure of Pemetrexed Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Injection Distributors
11.3 Pemetrexed Injection Customer
12 World Forecast Review for Pemetrexed Injection by Geographic Region
12.1 Global Pemetrexed Injection Market Size Forecast by Region
12.1.1 Global Pemetrexed Injection Forecast by Region (2023-2028)
12.1.2 Global Pemetrexed Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pemetrexed Injection Forecast by Type
12.7 Global Pemetrexed Injection Forecast by Application
13 Key Players Analysis
13.1 Eagle Pharmaceuticals
13.1.1 Eagle Pharmaceuticals Company Information
13.1.2 Eagle Pharmaceuticals Pemetrexed Injection Product Offered
13.1.3 Eagle Pharmaceuticals Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eagle Pharmaceuticals Main Business Overview
13.1.5 Eagle Pharmaceuticals Latest Developments
13.2 AuroMedics Pharma
13.2.1 AuroMedics Pharma Company Information
13.2.2 AuroMedics Pharma Pemetrexed Injection Product Offered
13.2.3 AuroMedics Pharma Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AuroMedics Pharma Main Business Overview
13.2.5 AuroMedics Pharma Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Pemetrexed Injection Product Offered
13.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Taro Pharma
13.4.1 Taro Pharma Company Information
13.4.2 Taro Pharma Pemetrexed Injection Product Offered
13.4.3 Taro Pharma Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Taro Pharma Main Business Overview
13.4.5 Taro Pharma Latest Developments
13.5 Seacross Pharmaceuticals
13.5.1 Seacross Pharmaceuticals Company Information
13.5.2 Seacross Pharmaceuticals Pemetrexed Injection Product Offered
13.5.3 Seacross Pharmaceuticals Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Seacross Pharmaceuticals Main Business Overview
13.5.5 Seacross Pharmaceuticals Latest Developments
13.6 Simcere Pharmaceutical Group
13.6.1 Simcere Pharmaceutical Group Company Information
13.6.2 Simcere Pharmaceutical Group Pemetrexed Injection Product Offered
13.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Simcere Pharmaceutical Group Main Business Overview
13.6.5 Simcere Pharmaceutical Group Latest Developments
13.7 Qilu Pharmaceutical
13.7.1 Qilu Pharmaceutical Company Information
13.7.2 Qilu Pharmaceutical Pemetrexed Injection Product Offered
13.7.3 Qilu Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Qilu Pharmaceutical Main Business Overview
13.7.5 Qilu Pharmaceutical Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Pemetrexed Injection Product Offered
13.8.3 Pfizer Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Jiangsu Anda Pharmaceutical
13.9.1 Jiangsu Anda Pharmaceutical Company Information
13.9.2 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Offered
13.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu Anda Pharmaceutical Main Business Overview
13.9.5 Jiangsu Anda Pharmaceutical Latest Developments
13.10 Yangtze River Pharmaceutical Group
13.10.1 Yangtze River Pharmaceutical Group Company Information
13.10.2 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Offered
13.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Yangtze River Pharmaceutical Group Main Business Overview
13.10.5 Yangtze River Pharmaceutical Group Latest Developments
13.11 Hansoh Pharmaceutical Group Company?????
13.11.1 Hansoh Pharmaceutical Group Company????? Company Information
13.11.2 Hansoh Pharmaceutical Group Company????? Pemetrexed Injection Product Offered
13.11.3 Hansoh Pharmaceutical Group Company????? Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hansoh Pharmaceutical Group Company????? Main Business Overview
13.11.5 Hansoh Pharmaceutical Group Company????? Latest Developments
13.12 Nanjing Pharmaceutical Factory
13.12.1 Nanjing Pharmaceutical Factory Company Information
13.12.2 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Offered
13.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nanjing Pharmaceutical Factory Main Business Overview
13.12.5 Nanjing Pharmaceutical Factory Latest Developments
13.13 DEYAO PHARMA
13.13.1 DEYAO PHARMA Company Information
13.13.2 DEYAO PHARMA Pemetrexed Injection Product Offered
13.13.3 DEYAO PHARMA Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 DEYAO PHARMA Main Business Overview
13.13.5 DEYAO PHARMA Latest Developments
13.14 Vianex S.A.-Plant C
13.14.1 Vianex S.A.-Plant C Company Information
13.14.2 Vianex S.A.-Plant C Pemetrexed Injection Product Offered
13.14.3 Vianex S.A.-Plant C Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Vianex S.A.-Plant C Main Business Overview
13.14.5 Vianex S.A.-Plant C Latest Developments
13.15 Hainan Jinrui Pharmaceutical
13.15.1 Hainan Jinrui Pharmaceutical Company Information
13.15.2 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Offered
13.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Hainan Jinrui Pharmaceutical Main Business Overview
13.15.5 Hainan Jinrui Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Pemetrexed Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pemetrexed Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.5g Bottle
Table 4. Major Players of 0.2g Bottle
Table 5. Global Pemetrexed Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Pemetrexed Injection Sales Market Share by Type (2017-2022)
Table 7. Global Pemetrexed Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pemetrexed Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Pemetrexed Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pemetrexed Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Pemetrexed Injection Sales Market Share by Application (2017-2022)
Table 12. Global Pemetrexed Injection Revenue by Application (2017-2022)
Table 13. Global Pemetrexed Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Pemetrexed Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pemetrexed Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Pemetrexed Injection Sales Market Share by Company (2020-2022)
Table 17. Global Pemetrexed Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pemetrexed Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Pemetrexed Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pemetrexed Injection Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Injection Products Offered
Table 22. Pemetrexed Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pemetrexed Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pemetrexed Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pemetrexed Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pemetrexed Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pemetrexed Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pemetrexed Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pemetrexed Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pemetrexed Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pemetrexed Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pemetrexed Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Pemetrexed Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pemetrexed Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Pemetrexed Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pemetrexed Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Pemetrexed Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pemetrexed Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Pemetrexed Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pemetrexed Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Pemetrexed Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pemetrexed Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Pemetrexed Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pemetrexed Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Pemetrexed Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pemetrexed Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Pemetrexed Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pemetrexed Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Pemetrexed Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pemetrexed Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Pemetrexed Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pemetrexed Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Pemetrexed Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pemetrexed Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pemetrexed Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pemetrexed Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pemetrexed Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pemetrexed Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pemetrexed Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pemetrexed Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pemetrexed Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pemetrexed Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pemetrexed Injection
Table 66. Key Market Challenges & Risks of Pemetrexed Injection
Table 67. Key Industry Trends of Pemetrexed Injection
Table 68. Pemetrexed Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pemetrexed Injection Distributors List
Table 71. Pemetrexed Injection Customer List
Table 72. Global Pemetrexed Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pemetrexed Injection Sales Market Forecast by Region
Table 74. Global Pemetrexed Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pemetrexed Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pemetrexed Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pemetrexed Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pemetrexed Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pemetrexed Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pemetrexed Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pemetrexed Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pemetrexed Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pemetrexed Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pemetrexed Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pemetrexed Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pemetrexed Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pemetrexed Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pemetrexed Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pemetrexed Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pemetrexed Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pemetrexed Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Eagle Pharmaceuticals Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Eagle Pharmaceuticals Pemetrexed Injection Product Offered
Table 94. Eagle Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Eagle Pharmaceuticals Main Business
Table 96. Eagle Pharmaceuticals Latest Developments
Table 97. AuroMedics Pharma Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. AuroMedics Pharma Pemetrexed Injection Product Offered
Table 99. AuroMedics Pharma Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. AuroMedics Pharma Main Business
Table 101. AuroMedics Pharma Latest Developments
Table 102. Teva Pharmaceutical Industries Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Pemetrexed Injection Product Offered
Table 104. Teva Pharmaceutical Industries Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Teva Pharmaceutical Industries Main Business
Table 106. Teva Pharmaceutical Industries Latest Developments
Table 107. Taro Pharma Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Taro Pharma Pemetrexed Injection Product Offered
Table 109. Taro Pharma Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Taro Pharma Main Business
Table 111. Taro Pharma Latest Developments
Table 112. Seacross Pharmaceuticals Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Seacross Pharmaceuticals Pemetrexed Injection Product Offered
Table 114. Seacross Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Seacross Pharmaceuticals Main Business
Table 116. Seacross Pharmaceuticals Latest Developments
Table 117. Simcere Pharmaceutical Group Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Simcere Pharmaceutical Group Pemetrexed Injection Product Offered
Table 119. Simcere Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Simcere Pharmaceutical Group Main Business
Table 121. Simcere Pharmaceutical Group Latest Developments
Table 122. Qilu Pharmaceutical Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Qilu Pharmaceutical Pemetrexed Injection Product Offered
Table 124. Qilu Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Qilu Pharmaceutical Main Business
Table 126. Qilu Pharmaceutical Latest Developments
Table 127. Pfizer Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Pfizer Pemetrexed Injection Product Offered
Table 129. Pfizer Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Pfizer Main Business
Table 131. Pfizer Latest Developments
Table 132. Jiangsu Anda Pharmaceutical Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Offered
Table 134. Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Jiangsu Anda Pharmaceutical Main Business
Table 136. Jiangsu Anda Pharmaceutical Latest Developments
Table 137. Yangtze River Pharmaceutical Group Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Yangtze River Pharmaceutical Group Pemetrexed Injection Product Offered
Table 139. Yangtze River Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Yangtze River Pharmaceutical Group Main Business
Table 141. Yangtze River Pharmaceutical Group Latest Developments
Table 142. Hansoh Pharmaceutical Group Company????? Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Hansoh Pharmaceutical Group Company????? Pemetrexed Injection Product Offered
Table 144. Hansoh Pharmaceutical Group Company????? Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Hansoh Pharmaceutical Group Company????? Main Business
Table 146. Hansoh Pharmaceutical Group Company????? Latest Developments
Table 147. Nanjing Pharmaceutical Factory Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Nanjing Pharmaceutical Factory Pemetrexed Injection Product Offered
Table 149. Nanjing Pharmaceutical Factory Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Nanjing Pharmaceutical Factory Main Business
Table 151. Nanjing Pharmaceutical Factory Latest Developments
Table 152. DEYAO PHARMA Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. DEYAO PHARMA Pemetrexed Injection Product Offered
Table 154. DEYAO PHARMA Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. DEYAO PHARMA Main Business
Table 156. DEYAO PHARMA Latest Developments
Table 157. Vianex S.A.-Plant C Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 158. Vianex S.A.-Plant C Pemetrexed Injection Product Offered
Table 159. Vianex S.A.-Plant C Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Vianex S.A.-Plant C Main Business
Table 161. Vianex S.A.-Plant C Latest Developments
Table 162. Hainan Jinrui Pharmaceutical Basic Information, Pemetrexed Injection Manufacturing Base, Sales Area and Its Competitors
Table 163. Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Offered
Table 164. Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Hainan Jinrui Pharmaceutical Main Business
Table 166. Hainan Jinrui Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Pemetrexed Injection
Figure 2. Pemetrexed Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pemetrexed Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pemetrexed Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.5g Bottle
Figure 10. Product Picture of 0.2g Bottle
Figure 11. Global Pemetrexed Injection Sales Market Share by Type in 2021
Figure 12. Global Pemetrexed Injection Revenue Market Share by Type (2017-2022)
Figure 13. Pemetrexed Injection Consumed in Non Squamous Non-Small Cell Lung Cancer
Figure 14. Global Pemetrexed Injection Market: Non Squamous Non-Small Cell Lung Cancer (2017-2022) & (K Units)
Figure 15. Pemetrexed Injection Consumed in Squamous Cell Non-Small Cell Lung Cancer
Figure 16. Global Pemetrexed Injection Market: Squamous Cell Non-Small Cell Lung Cancer (2017-2022) & (K Units)
Figure 17. Global Pemetrexed Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Pemetrexed Injection Revenue Market Share by Application in 2021
Figure 19. Pemetrexed Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Pemetrexed Injection Revenue Market Share by Company in 2021
Figure 21. Global Pemetrexed Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Pemetrexed Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Pemetrexed Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Pemetrexed Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Pemetrexed Injection Sales 2017-2022 (K Units)
Figure 26. Americas Pemetrexed Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Pemetrexed Injection Sales 2017-2022 (K Units)
Figure 28. APAC Pemetrexed Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Pemetrexed Injection Sales 2017-2022 (K Units)
Figure 30. Europe Pemetrexed Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Pemetrexed Injection Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Pemetrexed Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Pemetrexed Injection Sales Market Share by Country in 2021
Figure 34. Americas Pemetrexed Injection Revenue Market Share by Country in 2021
Figure 35. United States Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Pemetrexed Injection Sales Market Share by Region in 2021
Figure 40. APAC Pemetrexed Injection Revenue Market Share by Regions in 2021
Figure 41. China Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Pemetrexed Injection Sales Market Share by Country in 2021
Figure 48. Europe Pemetrexed Injection Revenue Market Share by Country in 2021
Figure 49. Germany Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Pemetrexed Injection Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Pemetrexed Injection Revenue Market Share by Country in 2021
Figure 56. Egypt Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Pemetrexed Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Pemetrexed Injection in 2021
Figure 62. Manufacturing Process Analysis of Pemetrexed Injection
Figure 63. Industry Chain Structure of Pemetrexed Injection
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)